EVIDENCE FOR AN EFFECT OF ANTITHYROID DRUGS ON THE NATURAL-HISTORY OF GRAVES-DISEASE

被引：145
作者：
WEETMAN, AP
MCGREGOR, AM
HALL, R
机构：
来源：
CLINICAL ENDOCRINOLOGY | 1984年 / 21卷 / 02期
关键词：
D O I：
10.1111/j.1365-2265.1984.tb03456.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：163 / 172
页数：10
相关论文
共 63 条
[1]  
ALEXANDE.WD, 1965, LANCET, V2, P866
[2]  
ALEXANDER W D, 1973, Clinical Endocrinology, V2, P43, DOI 10.1111/j.1365-2265.1973.tb03483.x
[3]   DEVELOPMENT OF THYROIDAL SUPPRESSION BY TRIIODOTHYRONINE DURING 6 MONTHS TREATMENT OF THYROTOXICOSIS WITH ANTITHYROID DRUGS [J].
ALEXANDER, WD ;
HARDEN, RM ;
SHIMMINS, J ;
MCLARTY, D ;
MCGILL, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (12) :1682-+
[4]   A PROSPECTIVE-STUDY OF THE RELATIONSHIP BETWEEN RELAPSE OF HYPERTHYROID GRAVES-DISEASE AFTER ANTI-THYROID DRUGS AND HLA HAPLOTYPE [J].
ALLANNIC, H ;
FAUCHET, R ;
LORCY, Y ;
GUEGUEN, M ;
LEGUERRIER, AM ;
GENETET, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (04) :719-722
[5]  
ALQUIST J, 1976, ACTA ENDOCRINOLOGI S, V206, P1
[6]   LYMPHOCYTE-T SUBPOPULATIONS IN GRAVES-DISEASE - RELATIONSHIP WITH CLINICAL CONDITIONS [J].
BAGNASCO, M ;
CANONICA, GW ;
FERRINI, S ;
BIASSONI, P ;
MELIOLI, G ;
FERRINI, O ;
GIORDANO, G .
ACTA ENDOCRINOLOGICA, 1983, 102 (02) :213-219
[7]  
BONNYNS M, 1983, CLIN EXP IMMUNOL, V52, P629
[8]   THYROID-HORMONE AND IMMUNOLOGICAL STUDIES IN ENDEMIC GOITER [J].
BOUKIS, MA ;
KOUTRAS, DA ;
SOUVATZOGLOU, A ;
EVANGELOPOULOU, A ;
VRONTAKIS, M ;
MOULOPOULOS, SD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (04) :859-862
[9]  
DAHLBERG PA, 1982, 64TH AM END SOC ANN
[10]  
DAVIES TF, 1977, LANCET, V1, P1181
1234567